PL2931289T3 - Chityna lub jej pochodne do zapobiegania i/lub leczenia parazytoz - Google Patents

Chityna lub jej pochodne do zapobiegania i/lub leczenia parazytoz

Info

Publication number
PL2931289T3
PL2931289T3 PL13818279T PL13818279T PL2931289T3 PL 2931289 T3 PL2931289 T3 PL 2931289T3 PL 13818279 T PL13818279 T PL 13818279T PL 13818279 T PL13818279 T PL 13818279T PL 2931289 T3 PL2931289 T3 PL 2931289T3
Authority
PL
Poland
Prior art keywords
parasitoses
chitin
prevention
derivatives
treatment
Prior art date
Application number
PL13818279T
Other languages
English (en)
Inventor
Eric Auclair
Jean-Philippe MARDEN
Fabrice Laurent
Sonia LACROIX-LAMANDE
Original Assignee
Lesaffre Et Compagnie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesaffre Et Compagnie filed Critical Lesaffre Et Compagnie
Publication of PL2931289T3 publication Critical patent/PL2931289T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL13818279T 2012-12-14 2013-12-10 Chityna lub jej pochodne do zapobiegania i/lub leczenia parazytoz PL2931289T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1262072A FR2999428B1 (fr) 2012-12-14 2012-12-14 Chitine ou derives de chitine pour utilisation dans la prevention et/ou le traitement de parasitoses
PCT/FR2013/053010 WO2014091138A1 (fr) 2012-12-14 2013-12-10 Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
EP13818279.5A EP2931289B1 (fr) 2012-12-14 2013-12-10 Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses

Publications (1)

Publication Number Publication Date
PL2931289T3 true PL2931289T3 (pl) 2019-09-30

Family

ID=48128453

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13818279T PL2931289T3 (pl) 2012-12-14 2013-12-10 Chityna lub jej pochodne do zapobiegania i/lub leczenia parazytoz

Country Status (13)

Country Link
US (1) US9717751B2 (pl)
EP (1) EP2931289B1 (pl)
CN (1) CN104870002B (pl)
AU (1) AU2013357117A1 (pl)
BR (1) BR112015013783A2 (pl)
CA (1) CA2894013A1 (pl)
ES (1) ES2734994T3 (pl)
FR (1) FR2999428B1 (pl)
HU (1) HUE044216T2 (pl)
PL (1) PL2931289T3 (pl)
RU (1) RU2015122255A (pl)
TN (1) TN2015000255A1 (pl)
WO (1) WO2014091138A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3078948C (en) * 2017-10-13 2024-03-26 Corning Incorporated Method for encapsulating hydrophobic materials in stabilized yeast cells suitable for processing with polymers
US20210228661A1 (en) * 2018-06-13 2021-07-29 Fermentationexperts A/S Anti-parasitic composition
CN109007366A (zh) * 2018-08-20 2018-12-18 桐城市雨润生物科技有限公司 一种含百里香精油的仔猪浓缩饲料
WO2021011818A1 (en) * 2019-07-16 2021-01-21 Ralco Nutrition, Inc Feed compositions
CN111040973B (zh) * 2019-12-30 2021-12-03 江南大学 一株可高产2种形态有机硒的鼠李糖乳杆菌及其应用
CN111513211A (zh) * 2020-06-01 2020-08-11 广州市天朝生物科技有限公司 一种用于畜禽与水产养殖的水溶性营养精油及其制备方法和应用
FR3115455A1 (fr) * 2020-10-28 2022-04-29 Lesaffre Et Compagnie Levure Saccharomyces Cerevisiae pour la prévention et/ou le traitement de parasitoses
US11735310B2 (en) * 2020-12-29 2023-08-22 Kpn Innovations, Llc. Systems and methods for generating a parasitic infection nutrition program
US12263198B1 (en) 2021-01-15 2025-04-01 Ralco Nutrition, Inc. Compositions and methods of improving ruminant performance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608964D0 (en) 1986-04-12 1986-05-14 Pannell N A Producing microbially encapsulated materials
KR0185267B1 (ko) * 1996-03-14 1999-05-01 김선규 카이토산 또는 카이토산올리고머 또는 이들의 혼합물을 유효성분으로 하는 어병치료제
JP2001081007A (ja) * 1999-09-10 2001-03-27 Oji Paper Co Ltd 天然物由来殺菌剤
KR100474945B1 (ko) * 2002-01-10 2005-03-10 알앤엘생명과학주식회사 젖소의 원유 중 체세포 감소용 및 유방염의 예방 또는치료용 조성물
US6841173B2 (en) * 2002-03-26 2005-01-11 Peter L. Reynolds Compositions and methods directed towards sore muscles and joints
CN1692782A (zh) * 2005-06-26 2005-11-09 苟春虎 降压好酸奶片
US8304226B2 (en) * 2006-08-22 2012-11-06 Carl Miller Quality of life of hepatitis C patients with a formulation for administration to the oral mucosa including freeze dried lysate of selected Lactobacillus or Bifidobacterium species and N-acetyl D-glucosamine
KR100799652B1 (ko) * 2006-09-27 2008-01-31 장태현 셀레늄과 게르마늄을 함유한 느타리버섯 생산용 배지조성물 및 이를 이용하여 느타리버섯을 재배하는 방법
JP2010265194A (ja) * 2009-05-13 2010-11-25 Sankai Kasei Kk 動物の病原菌排除方法

Also Published As

Publication number Publication date
CA2894013A1 (fr) 2014-06-19
EP2931289B1 (fr) 2019-04-17
WO2014091138A1 (fr) 2014-06-19
ES2734994T3 (es) 2019-12-13
US20150297632A1 (en) 2015-10-22
US9717751B2 (en) 2017-08-01
NZ709025A (en) 2020-12-18
CN104870002A (zh) 2015-08-26
HUE044216T2 (hu) 2019-10-28
TN2015000255A1 (fr) 2016-10-03
EP2931289A1 (fr) 2015-10-21
BR112015013783A2 (pt) 2017-07-11
CN104870002B (zh) 2019-07-23
RU2015122255A (ru) 2017-01-19
FR2999428B1 (fr) 2016-08-19
AU2013357117A1 (en) 2015-07-02
FR2999428A1 (fr) 2014-06-20

Similar Documents

Publication Publication Date Title
ZA201500921B (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases
EP3068289A4 (en) Prevention and treatment of bed exits, falls, and other conditions
IL237528A0 (en) Methods for preventing and treating preeclampsia
PL2818481T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi złośliwemu
PL2931289T3 (pl) Chityna lub jej pochodne do zapobiegania i/lub leczenia parazytoz
IL239368A0 (en) Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system
GB201217296D0 (en) Method of treatment and/or prevention
EP2817018A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
EP2928470A4 (en) THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
AP2015008338A0 (en) Compounds for the treatment and prevention of retroviral infections
IL239309A0 (en) Methods for the treatment and prevention of respiratory conditions
IL238126B (en) Compositions for the treatment and prevention of obesity
IL237389A0 (en) Short interfering RNA and its use in methods and preparations for the treatment and/or prevention of eye diseases
EP2934501A4 (en) USES AND METHOD FOR THE TREATMENT OF LIVER DISEASES OR DRESSES
IL237403B (en) Short interfering RNA and its use in methods and preparations for the treatment and/or prevention of eye diseases
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
EP3079657B8 (en) Preparation for prevention and/or treatment of peri-implantitis
AU2014353885B2 (en) Prevention and treatment of toxicosis
GB201213968D0 (en) Prevention and treatment of osteoarthritis
SG2013079843A (en) Use of tocotrienols in the treatment or prevention of ulcerative colitis
EP2838526A4 (en) MATERIALS AND METHODS FOR PREVENTING AND TREATING VIRAL INFECTIONS
AP2015008726A0 (en) Low-glycerin-formulations for hiv treatment and prevention
GB201219696D0 (en) Agents for the prevention and/or treatment of central nervous system damamge
AU2012902706A0 (en) Prevention and treatment of haematological conditions